What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease / / edited by Branislav G. Baskot.
The mortality from ischemic heart disease has decreased in recent years. The better understanding of risk factors associated with development of coronary artery disease has significantly contributed to this decline. Improvements in medical and interventional therapy have reduced the complications as...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | ©2013 Rijeka, Croatia : : IntechOpen,, 2013. |
Year of Publication: | 2013 |
Language: | English |
Physical Description: | 1 online resource (484 pages) :; illustrations |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993600261704498 |
---|---|
ctrlnum |
(CKB)4970000000098609 (NjHacI)994970000000098609 (oapen)https://directory.doabooks.org/handle/20.500.12854/66469 (EXLCZ)994970000000098609 |
collection |
bib_alma |
record_format |
marc |
spelling |
Baskot, Branislav G. edt What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease / edited by Branislav G. Baskot. IntechOpen 2013 ©2013 Rijeka, Croatia : IntechOpen, 2013. 1 online resource (484 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on: online resource; title from PDF information screen (InTech, viewed October 18, 2022). The mortality from ischemic heart disease has decreased in recent years. The better understanding of risk factors associated with development of coronary artery disease has significantly contributed to this decline. Improvements in medical and interventional therapy have reduced the complications associated with acute myocardial infarction as well as revascularization. After the introduction of imaging modalities, the noninvasive characterization of regional function, perfusion and metabolism allowed for more sophisticated tissue characterization to identify reversible dysfunction with high diagnostic and prognostic accuracy. We now can legitimately claim that computed tomography angiography (CTA) of the coronary arteries is available. In the evaluation of patients with suspected coronary artery disease, many guidelines today consider CTA an alternative to stress testing. However the nuclear technique most frequently used by cardiologists is myocardial perfusion imaging (MPI). The combination of a nuclear camera with CTA allows for the attainment of coronary anatomic, cardiac function and MPI from one piece of equipment. Assessing cardiac viability is now fairly routine with these enhancements to cardiac imaging. Traditional coronary angiography presents a variety of limitations related to image acquisition, content, interpretation, and patient safety. Barriers to such improvements include the paucity of clinical outcomes studies related to new imaging technology, the need for physician and staff member training, and the costs associated with acquiring and effectively using these advances in coronary angiography. This issue is full of important information that every cardiologist needs to now. English Myocardial reperfusion. Cardiovascular medicine 953-51-1043-8 Baskot, Branislav G., editor. |
language |
English |
format |
eBook |
author2 |
Baskot, Branislav G., |
author_facet |
Baskot, Branislav G., |
author2_variant |
b g b bg bgb b g b bg bgb |
author2_role |
TeilnehmendeR |
title |
What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease / |
spellingShingle |
What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease / |
title_full |
What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease / edited by Branislav G. Baskot. |
title_fullStr |
What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease / edited by Branislav G. Baskot. |
title_full_unstemmed |
What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease / edited by Branislav G. Baskot. |
title_auth |
What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease / |
title_new |
What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease / |
title_sort |
what should we know about prevented, diagnostic, and interventional therapy in coronary artery disease / |
publisher |
IntechOpen IntechOpen, |
publishDate |
2013 |
physical |
1 online resource (484 pages) : illustrations |
isbn |
953-51-7116-X 953-51-1043-8 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC685 |
callnumber-sort |
RC 3685 I6 W438 42013 |
illustrated |
Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.124 |
dewey-sort |
3616.124 |
dewey-raw |
616.124 |
dewey-search |
616.124 |
work_keys_str_mv |
AT baskotbranislavg whatshouldweknowaboutpreventeddiagnosticandinterventionaltherapyincoronaryarterydisease |
status_str |
n |
ids_txt_mv |
(CKB)4970000000098609 (NjHacI)994970000000098609 (oapen)https://directory.doabooks.org/handle/20.500.12854/66469 (EXLCZ)994970000000098609 |
carrierType_str_mv |
cr |
is_hierarchy_title |
What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796653160890105857 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01048nam a2200289 i 4500</leader><controlfield tag="001">993600261704498</controlfield><controlfield tag="005">20221018080215.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">221018s2013 ci a o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">953-51-7116-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4970000000098609</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994970000000098609</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/66469</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994970000000098609</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC685.I6</subfield><subfield code="b">.W438 2013</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.124</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Baskot, Branislav G.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease /</subfield><subfield code="c">edited by Branislav G. Baskot.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2013</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2013</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Rijeka, Croatia :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2013.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (484 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (InTech, viewed October 18, 2022).</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The mortality from ischemic heart disease has decreased in recent years. The better understanding of risk factors associated with development of coronary artery disease has significantly contributed to this decline. Improvements in medical and interventional therapy have reduced the complications associated with acute myocardial infarction as well as revascularization. After the introduction of imaging modalities, the noninvasive characterization of regional function, perfusion and metabolism allowed for more sophisticated tissue characterization to identify reversible dysfunction with high diagnostic and prognostic accuracy. We now can legitimately claim that computed tomography angiography (CTA) of the coronary arteries is available. In the evaluation of patients with suspected coronary artery disease, many guidelines today consider CTA an alternative to stress testing. However the nuclear technique most frequently used by cardiologists is myocardial perfusion imaging (MPI). The combination of a nuclear camera with CTA allows for the attainment of coronary anatomic, cardiac function and MPI from one piece of equipment. Assessing cardiac viability is now fairly routine with these enhancements to cardiac imaging. Traditional coronary angiography presents a variety of limitations related to image acquisition, content, interpretation, and patient safety. Barriers to such improvements include the paucity of clinical outcomes studies related to new imaging technology, the need for physician and staff member training, and the costs associated with acquiring and effectively using these advances in coronary angiography. This issue is full of important information that every cardiologist needs to now.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Myocardial reperfusion.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Cardiovascular medicine</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">953-51-1043-8</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Baskot, Branislav G.,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-05-24 19:51:08 Europe/Vienna</subfield><subfield code="f">System</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-04-13 22:04:18 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5345719060004498&Force_direct=true</subfield><subfield code="Z">5345719060004498</subfield><subfield code="b">Available</subfield><subfield code="8">5345719060004498</subfield></datafield></record></collection> |